Skip to Content

Tag: holding company

Also Noted

Oncologix updates on earnings

April 16, 2015HME News Staff

LAFAYETTE, La. - Oncologix, a diversified medical holding company with operating divisions in medical devices, healthcare services and DME sales and distribution, expects to grow annualized revenues to $25 million by the end of 2015, it announced April 14. It also expects to achieve positive EBITDA of more than $2.6 million. “Our stock price does not accurately reflect the hard work and success of our operating activities and it remains severely undervalued,” CEO Wayne Erwin stated in...

Earnings, holding company, Oncologix

Read Full Articlered right arrow icon